Navigation Links
Axela Inc. Retains Investment Bank to Evaluate Strategic Opportunities

TORONTO, Feb. 1, 2013 /PRNewswire/ -- Axela Inc. announced it has appointed AmeriTech Advisors healthcare investment banking team to respond to recent strategic interest from life science industry companies. This involves licensing or sale of rights to certain of the company's recently developed multiplex tests and proprietary platform technologies.

Over the last 2 years Axela has successfully transformed itself from being an engineering based, life-science tools company, into a strategically focused solutions provider, poised to exploit large market opportunities in Cancer, Immunology, Specialty Diagnostic and Life Science markets.  Axela has focused its MDX applications on rapidly growing markets which demand the combination of high numbers of gene and/or protein markers, rapid results and competitive pricing.

Axela's Flow-thru Array® platform addresses the gap that exists between multiplexed nucleic acid PCR and high density DNA/RNA arrays. The Ziplex® platform is more cost effective and unlike existing approaches, can be readily integrated into established laboratory workflows while  measuring 125-150 genes.  Recently, capabilities have been expanded to include fully automated multiplex protein analysis, offering significant advantages over bead or plate based platforms.  Ziplex, which is patented with extensive freedom to operate, can simultaneously measure more than 50 proteins rapidly while consuming only a few microliters of sample.  Performance has been demonstrated in infectious diseases, traumatic brain injury, and allergy testing applications.

Axela has also significantly advanced the company's second generation diffractive optics platform in collaboration with SONY DADC as part of a development program called ClearDx. The result is a cost efficient and very flexible protein multiplexing platform designed to move the delivery of Personalized Medicine closer to the patient. The platform is supported by a large patent estate and is uniquely well positioned to deliver highly informative assays in multiplex format (32+) at the point of use for human and veterinary diagnostics, research or bioproduction monitoring.

Strategic alternatives the Company may pursue could include a merger, partnering or other collaboration agreements, an equity or debt financing, sale of the Company or other strategic transactions.  The Company does not intend to disclose developments with respect to this process until the evaluation of strategic alternatives has been completed and the board of directors has approved a specific transaction.

About AmeriTech Advisors
AmeriTech is an investment bank dedicated to providing capital raising and strategic advisory services to emerging growth companies in the technology and medtech sectors with market capitalizations of between $25 million and $500 million. Their bankers have 20 years' experience at major global investment banks and as senior managers at public companies with experience executing successful transactions. Their goal is to build mutually beneficial relationships between our emerging growth company clients, technology and medtech/pharma partners, and their network of investors.

Dan D'Agostino
Managing Director
AmeriTech Advisors
708 Third Avenue, 5th fl.
New York, NY 10017
T: 212-209-3885
C: 917-596-9870
F: 212-209-7101



SOURCE AmeriTech Advisors
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
2. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
3. Life Technologies to Present at Upcoming Investment Conferences in February
4. New investment aims to establish the UK as a global graphene research hub
5. Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
6. City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters
7. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
8. Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives
9. Foundation Venture Capital Group Makes Eighth Start-Up Investment
10. Israeli Ministry of Finance Hosts Israel Investment, Innovation and Trade Forum in New York
11. David Lichtenstein: Biotechnology is Rich Area for Investment
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015 Celemics, a global ... into the North American market with the establishment of ... and Europe , has secured ... Target Enrichment methodology and sample preparation for DNA sequencing ... both hereditary and somatic genetic testing more accurately, quickly, ...
(Date:10/8/2015)...  The ALS Association, in partnership with Prize4Life, is ... revolutionize communication technology solutions for people living with ALS. ... (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease that ... spinal cord. Eventually, people with ALS lose the ability ... to total paralysis and death within two to five ...
(Date:10/8/2015)... ... October 08, 2015 , ... ... an exclusive license agreement to develop and commercialize intellectual property rights belonging to ... agreement from February 2009, and affords exclusive worldwide rights to intellectual property based ...
(Date:10/7/2015)... Texas (PRWEB) , ... October 07, 2015 , ... ... Institute ( ) will present a public educational seminar on the latest ... Saturday, October 10th from 1:00 pm – 3:00 pm at the Hilton Dallas/Southlake ...
Breaking Biology Technology:
... Merrimack Pharmaceuticals today announced that it will present at the Jefferies 2010 Global Life Sciences Conference ... provide a company overview at 11:00am EDT , Wednesday, June 9, 2010 at ... , , ... , , , ...
... June 1 Diplomat Specialty Pharmacy, the ... launch of Navigator Health Services, an independent division of ... pharmacy industry. The announcement was made by Diplomat Specialty ... who says that Navigator Health Services was formed in ...
... Calif. , June 1 Epeius Biotechnologies Corporation ( ... "Advanced Phase I/II Evaluation of Tumor-Targeted Gene Delivery: Intravenous Rexin-G as ... the ASCO Annual Meeting on June 8, 2010 . The ... Stanford University Medical Center, Palo Alto CA. ...
Cached Biology Technology:
(Date:9/10/2015)... , Sept. 10, 2015 Pursuant ... Clinic Wellness to create an interactive, image-based health ... health and wellness kiosk.  The unique assessment quantifies ... a number that suggests an individual,s biological age ... values as measured by the kiosk. ...
(Date:9/8/2015)... , Sept. 8, 2015   TREW Marketing ... the new survey, Smart Marketing for Engineers TM ... 580 engineering professionals reveals insightful findings about engineers, preferences ... types of content engineers most value and trust, and ... Marketers targeting technical audiences grapple with how to ...
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... key concern for enterprises, banks, government organizations, telecommunications, ... and numeric keypads were previously being used to ... introduction of two-factor authentication, wherein individuals could gain ... two different components, such as hardware devices and ...
Breaking Biology News(10 mins):
... "We can make you and we can break you." If ... oxide would start something like that. But this song wouldn,t ... of Rice chemist James Tour demonstrates an environmentally friendly way ... version of single-atom-thick graphene expected to find use in all ...
... A novel approach detects genetically abnormal cells in the blood ... in tumor cells and increase in number with the severity ... The University of Texas MD Anderson Cancer Center report in ... patients in the study also had many times the number ...
... A University of Minnesota Medical School research team led ... a novel approach to ease the chronic and acute ... a mouse model of SCD, Gupta and University of ... that exhibited both musculoskeletal pain and temperature sensitivity, symptoms ...
Cached Biology News:
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
Application: For use as a carrier in nucleic acid purification and precipitation. Physical form: Solution in 10 mM Tris HCl, pH 7.4, 1 mM EDTA Concentration: 9-11 mg/mL Physical Form: buffered aqu...
... Note: Prepared by a modification of ... al., Biotechnol. Bioeng., 11 ... unit will yield an A 260 ... of water (1 cm light path). ...
... Unique, compact measuring instrument for calibrating ... compact design and the robust carrying case, ... both in the laboratory and on-site at ... easy to use because the individual channels ...
Biology Products: